In breast cancer, Gal-9 has been shown to have anti-metastatic potential, most likely by inducing tumor cell aggregation and reduced adhesion of breast cancer cells to the extracellular matrix, thus preventing metastasis and improving patient survival (55, 99). This evidence concerns the gene LGALS9 and breast carcinoma.